Table 7 Carcinogenic potency of the PAHs in the study area
PAHs | No of Rings | TEQF | (PAHc × TEQF) | ||||||
|---|---|---|---|---|---|---|---|---|---|
A | B | C | D | E | CN1 | CN2 | |||
Nap | 2 | 0.001 | 5.12E−05 | 7.03E−06 | 0.00 | 0.00 | 4.31E−06 | 3.88E−08 | 0.00 |
Apt | 3 | 0.001 | 4.67E−06 | 5.65E−05 | 0.00 | 7.24E−05 | 8.56E−06 | 7.01E−09 | 0.00 |
Aph | 3 | 0.001 | 4.98E−05 | 2.37E−05 | 2.43E−04 | 8.85E−06 | 3.30E−06 | 7.55E−07 | 4.27E−05 |
Flu | 3 | 0.001 | 3.87E−05 | 2.38E−05 | 6.70E−05 | 1.93E−05 | 7.04E−06 | 4.17E−07 | 2.01E−06 |
Phe | 3 | 0.001 | 1.41E−05 | 5.14E−05 | 3.45E−05 | 6.68E−06 | 2.98E−05 | 4.43E−06 | 8.60E−06 |
Ant | 3 | 0.01 | 1.04E−04 | 1.77E−05 | 1.15E−04 | 7.33E−05 | 1.53E−05 | 7.82E−07 | 1.26E−04 |
Fla | 4 | 0.001 | 1.29E−05 | 3.17E−05 | 3.72E−06 | 6.60E−06 | 1.57E−05 | 3.75E−07 | 1.53E−05 |
Pyr | 4 | 0.001 | 6.87E−06 | 6.54E−06 | 4.46E−06 | 3.23E−06 | 3.19E−06 | 1.96E−07 | 5.39E−06 |
Ban | 4 | 0.10 | 4.22E−03 | 4.19E−04 | 9.81E−04 | 4.82E−04 | 1.38E−04 | 6.97E−05 | 1.19E−04 |
Chy | 4 | 0.01 | 1.25E−04 | 1.82E−04 | 1.06E−05 | 2.74E−05 | 1.12E−04 | 3.36E−05 | 5.90E−05 |
Bbf | 5 | 0.10 | 1.81E−03 | 1.45E−03 | 2.56E−05 | 8.21E−04 | 6.44E−04 | 2.36E−04 | 8.15E−04 |
Bkf | 5 | 0.10 | 2.51E−03 | 5.39E−04 | 3.09E−04 | 5.25E−04 | 2.01E−04 | 1.40E−04 | 6.96E−04 |
Indp | 6 | 1.00 | 5.63E−02 | 3.22E−02 | 9.56E−03 | 5.42E−02 | 1.21E−02 | 6.91E−02 | 4.44E−02 |
Dbh | 6 | 1.00 | 3.88E−01 | 7.85E−02 | 1.01E−01 | 9.64E−02 | 6.42E−02 | 1.39E−01 | 2.88E−01 |
BaPeq (mg/kg dm) |  |  | 4.53E−01 | 1.14E−01 | 1.12E−01 | 1.53E−01 | 7.75E−02 | 2.09E−01 | 3.34E−01 |